Dermatology Doctors in Salt Lake City, UT Accepting Medicare

69 Dermatology doctors found. Showing 61 - 69

Dr. Grace Collins Brummer, MD Dermatology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a330, Salt Lake City, UT 84132 Phone: 801-581-5509

Dr. Lucio Zapata Jr., MD Dermatology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a330, Salt Lake City, UT 84132 Phone: 801-581-6465

Dr. Alice Frigerio, MD, PHD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E, Som 4a330, Salt Lake City, UT 84132 Phone: 801-581-6465

Dr. Richard Lee Moss, M.D. Dermatology - Dermatopathology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-587-6340    Fax: 801-587-6346

Jordan L. Bormann, MD Dermatology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a330, Salt Lake City, UT 84132 Phone: 801-581-6465

Lauren Michelle Madigan, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4a330 School Of Medicine 30 North 1900 East, Salt Lake City, UT 84132 Phone: 801-581-2955

Dr. Marta J Petersen, M.D. Dermatology - Procedural Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2955

Spencer Bertoch, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E # 4a330, Salt Lake City, UT 84132 Phone: 801-581-6465

Sarah Elizabeth Dixon Cipriano, MD Dermatology - Pediatric Dermatology Medicare: Medicare Enrolled Practice Location: 100 N Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-581-2955

News Archive

Scientists work towards solving mystery of incurable blood diseases

Scientists may be on the road to solving the mystery of a group of mostly incurable blood diseases called myelodysplastic syndromes, which cause people to have immature, malfunctioning bone marrow cells that fuel a diverse set of health problems and can lead to leukemia.

CB&I signs definitive agreement with H2Gen Innovations to acquire PSA technology

CB&I (NYSE:CBI) announced today that it has entered into a definitive agreement with H2Gen Innovations, Inc., to acquire the Mars modularized Pressure Swing Adsorption (PSA) technology.

Lexicon Pharmaceuticals proposes $95 million underwritten public offering of common stock

Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.

General internists leaves practice sooner than internal medicine subspecialists, says ACP survey

A survey conducted by the American College of Physicians (ACP) and the American Board of Internal Medicine (ABIM) found that 9 percent of all internists originally certified between 1990 and 1995, including a significantly larger proportion of general internists (17 percent) than internal medicine subspecialists (4 percent), are no longer working in general internal medicine or one of its subspecialties about a decade after their original certification by ABIM.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3
• 4(current)